Nicoara Alina, Kretzer Adam, Cooter Mary, Bartz Raquel, Lyvers Jeffrey, Patel Chetan B, Schroder Jacob N, McCartney Sharon L, Podgoreanu Mihai V, Milano Carmelo A, Swaminathan Madhav, Stafford-Smith Mark
Department of Anesthesiology, Duke University Medical Center, Durham, NC, USA.
Department of Medicine, Duke University Medical Center, Durham, NC, USA.
Transpl Int. 2020 Aug;33(8):887-894. doi: 10.1111/tri.13615. Epub 2020 May 9.
Acute kidney injury (AKI) and primary graft dysfunction (PGD) are serious complications after heart transplantation (HT). The relationship between AKI and PGD is poorly understood. We sought to examine the incidence of AKI and identify risk factors associated with AKI. We hypothesized that PGD is one of the risk factors independently associated with post-HT AKI. We gathered data for all adult patients who underwent HT between 2009 and 2014. AKI was defined by the KDIGO criteria. PGD was categorized using ISHLT criteria. We assessed univariable and multivariable logistic regression to identify risk factors independently associated with post-HT AKI. Out of 316 patients, postoperative AKI occurred in 273 (86%) patients: 188 (68%) stage I, 44 (16%) stage II, and 41 (15%) stage III. Stage II/III AKI was associated with increased risk of mortality at 1 year. There was significant association between severe PGD and stage II/III AKI (P = 0.001, OR 3.63, 95% CI: 1.69-7.94). Other clinical factors significantly associated with stage II/III AKI included longer donor brain death duration and lower recipient baseline creatinine. We found that stage II/III AKI is common and independently associated with severe PGD. Another potentially modifiable risk factor is donor brain death duration.
急性肾损伤(AKI)和原发性移植肝无功能(PGD)是心脏移植(HT)后的严重并发症。AKI与PGD之间的关系尚不清楚。我们试图研究AKI的发生率,并确定与AKI相关的危险因素。我们假设PGD是与HT后AKI独立相关的危险因素之一。我们收集了2009年至2014年间所有接受HT的成年患者的数据。AKI根据KDIGO标准定义。PGD根据国际心脏和肺移植学会(ISHLT)标准进行分类。我们评估了单变量和多变量逻辑回归,以确定与HT后AKI独立相关的危险因素。在316例患者中,273例(86%)发生了术后AKI:188例(68%)为I期,44例(16%)为II期,41例(15%)为III期。II/III期AKI与1年死亡率增加相关。严重PGD与II/III期AKI之间存在显著关联(P = 0.001,OR 3.63,95%CI:1.69 - 7.94)。与II/III期AKI显著相关的其他临床因素包括供体脑死亡持续时间延长和受体基线肌酐水平较低。我们发现II/III期AKI很常见,且与严重PGD独立相关。另一个潜在的可改变危险因素是供体脑死亡持续时间。